Skip to main content
. 2005 May 21;11(19):2892–2899. doi: 10.3748/wjg.v11.i19.2892

Table 4.

Serum viral markers in two groups (cases) before treatment.

Group n HBsAg HBsAb HBeAg HBeAb HBcAb HBcAb-IM HBV-DNA
Experimental 110 110 3 48 48 105 40 38
Control 106 106 2 48 56 100 35 37
P 1.000 0.891 0.220 0.765 0.659 1.000